Spots Global Cancer Trial Database for stage iv adult hodgkin lymphoma

Every month we try and update this database with for stage iv adult hodgkin lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease	NCT00176475	Leukemia Lymphoma Multiple Myelom...	rituximab therapeutic all...	18 Years -	Rutgers, The State University of New Jersey
SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma	NCT00101244	Adult Grade III... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Waldenström Mac...	ispinesib laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma	NCT00981097	Lymphoma Nonneoplastic C...	polymerase chai... laboratory biom...	18 Years -	AIDS Malignancy Consortium
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma	NCT01165645	Hodgkin Lymphom... Stage I Adult H... Stage II Adult ... Stage III Adult... Stage IV Adult ...	lopinavir ritonavir polymerase chai... flow cytometry enzyme-linked i... laboratory biom...	18 Years -	Mayo Clinic
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma	NCT00002522	Lymphoma	cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera...	15 Years - 70 Years	Temple University
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma	NCT00003389	Lymphoma	Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy	16 Years -	Eastern Cooperative Oncology Group
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers	NCT00003572	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	peripheral bloo... mycophenolate m... tacrolimus allogeneic bone... radiation thera...	18 Years - 70 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma	NCT00369681	Lymphoma	Bleomycin Rituximab Dacarbazine Doxorubicin Vinblastine	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer	NCT00296023	Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo...	18 Years - 75 Years	University of California, San Francisco
Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma	NCT00265889	Lymphoma	filgrastim busulfan cyclophosphamid... etoposide melphalan autologous-auto... radiation thera...	18 Years -	Case Comprehensive Cancer Center
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy	NCT00003341	Anemia Leukemia Lymphoma Multiple Myelom...	epoetin alfa quality-of-life...	18 Years -	Memorial Sloan Kettering Cancer Center
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma	NCT00389506	Lymphoma	LMB-2 immunotox... cyclophosphamid... fludarabine pho... pharmacological...	18 Years -	National Institutes of Health Clinical Center (CC)
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer	NCT00782379	Leukemia Lymphoma Myelodysplastic...	busulfan cyclophosphamid... fludarabine pho... mycophenolate m... tacrolimus allogeneic hema... peripheral bloo...	18 Years - 60 Years	Northside Hospital, Inc.
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy	NCT01319526	Lymphoma Nonneoplastic C...	DNA analysis RNA analysis laboratory biom...	18 Years -	AIDS Malignancy Consortium
Tipifarnib in Treating Patients With Advanced Hematologic Cancer	NCT00005967	Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	tipifarnib	18 Years -	National Cancer Institute (NCI)
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years	NCT00079105	Lymphoma	bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul...	60 Years - 120 Years	Newcastle-upon-Tyne Hospitals NHS Trust
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	NCT00822120	Lymphoma Nonneoplastic C...	bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul...	18 Years - 60 Years	SWOG Cancer Research Network
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease	NCT00005613	Lymphoma	cyclophosphamid... etoposide BCNU	15 Years - 55 Years	H. Lee Moffitt Cancer Center and Research Institute
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy	NCT00006220	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	arsenic trioxid... tretinoin	15 Years -	Washington University School of Medicine
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease	NCT00002462	Lymphoma	bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera...	15 Years - 70 Years	European Organisation for Research and Treatment of Cancer - EORTC
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy	NCT01319526	Lymphoma Nonneoplastic C...	DNA analysis RNA analysis laboratory biom...	18 Years -	AIDS Malignancy Consortium
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma	NCT00041210	Lymphoma	bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera...	18 Years - 60 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma	NCT00003389	Lymphoma	Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy	16 Years -	Eastern Cooperative Oncology Group
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma	NCT01476410	Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Stage II Adult ... Stage III Adult... Stage IV Adult ...	brentuximab ved... doxorubicin hyd... vinblastine dacarbazine quality-of-life... DNA analysis RNA analysis fludeoxyglucose... positron emissi... laboratory biom... immunohistochem... polymorphism an...	60 Years -	Northwestern University
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease	NCT00002462	Lymphoma	bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera...	15 Years - 70 Years	European Organisation for Research and Treatment of Cancer - EORTC
Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma	NCT00678327	Lymphoma	bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul...	18 Years - 100 Years	University College, London
Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma	NCT00478062	Lymphoma	Hodgkin's antig... adjuvant therap...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma	NCT00101244	Adult Grade III... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Waldenström Mac...	ispinesib laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma	NCT00002522	Lymphoma	cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera...	15 Years - 70 Years	Temple University
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas	NCT02213913	Adult Grade III... B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Cutaneous B-cel... Extranodal Marg... Intraocular Lym... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Progressive Hai... Small Intestine... Splenic Margina... Stage 0 Chronic... Stage I Adult D... Stage I Adult D... Stage I Adult D... Stage I Adult H... Stage I Adult I... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Grade 3... Stage I Mantle ... Stage I Margina... Stage I Small L... Stage II Adult ... Stage II Chroni... Stage II Small ... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Testicular Lymp... Untreated Hairy... Waldenström Mac...	lenalidomide etoposide prednisone vincristine sul... doxorubicin hyd... cyclophosphamid... rituximab quality-of-life... laboratory biom...	18 Years -	University of Chicago
Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma	NCT00265889	Lymphoma	filgrastim busulfan cyclophosphamid... etoposide melphalan autologous-auto... radiation thera...	18 Years -	Case Comprehensive Cancer Center
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma	NCT00041210	Lymphoma	bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera...	18 Years - 60 Years	National Cancer Institute (NCI)
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer	NCT00004132	Drug/Agent Toxi... Leukemia Lymphoma Multiple Myelom... Oral Complicati... Radiation Toxic...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide quality-of-life... radiation thera...	12 Years - 65 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma	NCT00002715	Lymphoma	Bleomycin sulfa... Stanford V regi... Doxorubicin hyd... Etoposide Mechlorethamine... Prednisone Vinblastine Vincristine sul...	18 Years - 60 Years	Stanford University
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection	NCT02343666	Human Immunodef... Stage I Adult H... Stage I Adult N... Stage II Adult ... Stage II Adult ... Stage III Adult... Stage III Adult... Stage IV Adult ... Stage IV Adult ...	C46/CCR5/P140K ... Carmustine Filgrastim Laboratory Biom... O6-Benzylguanin... Plerixafor	18 Years - 66 Years	Fred Hutchinson Cancer Center
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer	NCT00006368	Brain and Centr... Breast Cancer Gastrointestina... Islet Cell Tumo... Lung Cancer Lymphoma Melanoma (Skin) Neoplastic Synd...	yttrium Y 90-ed...	18 Years -	Novartis
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma	NCT00389506	Lymphoma	LMB-2 immunotox... cyclophosphamid... fludarabine pho... pharmacological...	18 Years -	National Institutes of Health Clinical Center (CC)
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease	NCT00005613	Lymphoma	cyclophosphamid... etoposide BCNU	15 Years - 55 Years	H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma	NCT00006373	Lymphoma	etoposide ifosfamide topotecan hydro... autologous bone... Mesna	18 Years - 64 Years	H. Lee Moffitt Cancer Center and Research Institute
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers	NCT00619645	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	busulfan cyclosporine fludarabine pho... mycophenolate m... allogeneic hema... peripheral bloo...	18 Years - 120 Years	University of California, Davis
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies	NCT03044743	Stage IV Gastri... Stage IV Nasoph... T-Cell Lymphoma... Stage IV Adult ... Stage IV Diffus...	Fludarabine Cyclophosphamid... Interleukin-2	18 Years - 75 Years	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy	NCT00003341	Anemia Leukemia Lymphoma Multiple Myelom...	epoetin alfa quality-of-life...	18 Years -	Memorial Sloan Kettering Cancer Center
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer	NCT00296023	Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo...	18 Years - 75 Years	University of California, San Francisco
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers	NCT00003572	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	peripheral bloo... mycophenolate m... tacrolimus allogeneic bone... radiation thera...	18 Years - 70 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma	NCT00920153	Lymphoma	bleomycin sulfa... ABVD regimen carmustine cisplatin cytarabine dacarbazine dexamethasone doxorubicin hyd... etoposide gemcitabine hyd... ifosfamide melphalan methylprednisol... mitoguazone vincristine sul... vindesine vinorelbine tar... allogeneic hema... autologous hema...	18 Years - 65 Years	French Innovative Leukemia Organisation
Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma	NCT00288067	Adult Nodular L... B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Stage II Margin... Stage II Small ... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Splenic Margina... Stage I Adult B... Stage I Adult D... Stage I Adult H... Stage I Adult L... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Small L... Stage II Adult ... Stage II Chroni... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Waldenström Mac...	fenretinide rituximab	18 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer	NCT00004145	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	anti-thymocyte ... cyclophosphamid... fludarabine pho... peripheral bloo...	18 Years - 60 Years	University of Chicago

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: